Blocking DCIR mitigates colitis and prevents colorectal tumors by enhancing the GM-CSF-STAT5 pathway-Reference-Cited by-同舟云学术

Blocking DCIR mitigates colitis and prevents colorectal tumors by enhancing the GM-CSF-STAT5 pathway

Published:2022-08 Issue:5 Volume:40 Page:111158
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Sun Haiyang,Tang Ce,Chung Soo-Hyun,Ye Xiao-Qi,Makusheva Yulia,Han Wei,Kubo Masato,Shichino Shigeyuki,Ueha Satoshi,Matsushima Koji,Ikeo Kazuho,Asano Masahide,Iwakura Yoichiro^ORCID

Funder

Ministry of Education, Culture, Sports, Science and Technology

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference69 articles.

1. The gm-csf-Irf5 signaling Axis in eosinophils promotes antitumor immunity through activation of type 1 T cell responses;Arnold;J. Exp. Med.,2020

2. Growth retardation and early death of beta-1, 4-galactosyltransferase knockout mice with augmented proliferation and abnormal differentiation of epithelial cells;Asano;EMBO J.,1997

3. Apcs express dcir, A novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif;Bates;J. Immunol.,1999

4. Trimmomatic: a flexible trimmer for Illumina sequence data;Bolger;Bioinformatics,2014

5. Neutrophils, from marrow to microbes;Borregaard;Immunity,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration of Gut Mycobiota and Oxidative Stress to Decipher the Roles of C-Type Lectin Receptors in Inflammatory Bowel Diseases;Immunological Investigations;2024-08-08

2. Agonistic anti-DCIR antibody inhibits ITAM-mediated inflammatory signaling and promotes immune resolution;JCI Insight;2024-05-23

3. The human and mouse dendritic cell receptor DCIR binds to LRP1 N-glycans containing terminal galactoses, including the α-Gal antigen;2024-05-21

4. The C-type lectin DCIR contributes to the immune response and pathogenesis of colorectal cancer;Scientific Reports;2024-03-26

5. Inhibitory receptors of plasmacytoid dendritic cells as possible targets for checkpoint blockade in cancer;Frontiers in Immunology;2024-03-05